詳細資料

  • がん統合醫療誌

登載期間:2016年6月

Integrative Cancer Therapies

Title of Article Title of Article:

Comprehensive and Holistic Analysis of HT-29 Colorectal Cancer Cells and TumorBearing Nude Mouse Model: Interactions Among Fractions Derived From the Chinese Medicine Formula Tian Xian Liquid in Effects on Human Colorectal Carcinoma

Research author Research author:

Annballaw Bridget Leigh, MSc1 , Ho Pan Cheung, MPhil1 , Li-zhu Lin, MD2 , Tzi Bun Ng, PhD3 , Lixing Lao, PhD1 , Yanbo Zhang, PhD1 , Zhang-Jin Zhang, PhD1 , Yao Tong, PhD1 , and Stephen Cho Wing Sze, PhD

Research unit Research unit:

1The University of Hong Kong, Pokfulam, Hong Kong SAR, China
2First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou, Guangdong, China
3The Chinese University of Hong Kong, Shatin, NT, Hong Kong SAR, China

Research unit Conclusions:

In this study, the holistic effects of TXL were investigated, demonstrating the science-based (a) mutual accentuation and mutual enhancement, (b) mutual counteraction and mutual suppression, and (c) mutual antagonism. So, there is a better understanding of the comprehensive and holistic effects of Chinese medicine formula. Further research in this area may give hints to the development of a more effective fraction and its ingredients with minimal side effects for fighting against human colorectal carcinoma.

Journal Introduction Journal Introduction:

Integrative Cancer Therapies was established in 2002 as a prospective and innovative medical journal. It mainly collects professional papers regarding integrative medicine, traditional medicine for cancer therapies, which include diet care, life management, nutrition supplements, experimental vaccines, and any other therapy measure employing advance scientific approaches.

Impact Factor for 2011 is 2.136.

Link to Journal Link to Journal:

website address:http://ict.sagepub.com/

Disclaimer Disclaimer:

Pictures of this webpage are from the website of the Integrative Cancer Therapies (http://ict.sagepub.com/). All the privilege of intellectual property is owned by the Integrative Cancer Therapies.